Table 2 The correlations between clinicopathological characteristics and overall survival or recurrence-free survival of SCC patients using the Kaplan-Meier method
Variable | Overall Survival (months) Mean ± SE | P | Recurrence- Free Survival (months) Mean ± SE | P |
|---|---|---|---|---|
Age, y (mean ± SD) | 0.073 | 0.058 | ||
< =45 | 57.21 ± 1.75 | 57.07 ± 1.89 | ||
> 45 | 52.75 ± 1.87 | 51.32 ± 2.12 | ||
Stage | 0.060 | 0.107 | ||
I | 56.18 ± 1.41 | 55.03 ± 1.69 | ||
II | 48.17 ± 3.31 | 47.27 ± 3.60 | ||
Tumor size | 0.098 | 0.170 | ||
< =4 cm | 55.56 ± 1.61 | 54.41 ± 1.87 | ||
> 4 cm | 50.55 ± 2.94 | 49.61 ± 3.21 | ||
Lymphovascular invasion | 0.023 | 0.052 | ||
Negative | 57.05 ± 1.36 | 55.68 ± 1.86 | ||
Positive | 51.48 ± 2.25 | 50.53 ± 2.48 | ||
Stromal invasion depth | 0.067 | 0.058 | ||
< 1/2 | 57.60 ± 1.67 | 57.28 ± 1.89 | ||
> =1/2 | 51.52 ± 2.00 | 50.11 ± 2.25 | ||
Lymph node metastasis | < 0.001 | < 0.001 | ||
Negative | 57.71 ± 0.74 | 57.49 ± 0.86 | ||
Positive | 44.29 ± 3.86 | 41.29 ± 4.28 | ||
Parametrial invasion | 0.228 | 0.027 | ||
Negative | 56.65 ± 1.47 | 54.06 ± 1.62 | ||
Positive | 46.86 ± 6.65 | 39.86 ± 7.81 | ||
Margin | 0.531 | 0.573 | ||
Negative | 54.41 ± 1.48 | 53.34 ± 1.67 | ||
Positive | 48.25 ± 7.58 | 47.00 ± 8.66 | ||
Serum EV-Wnt 7b | < 0.001 | < 0.001 | ||
Low | 58.43 ± 0.56 | 58.35 ± 0.64 | ||
High | 49.00 ± 2.69 | 46.90 ± 3.02 | ||